Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis

The effect of hyperbaric oxygen treatment (HBOT) was examined using MSG mice, which are an animal model of obesity, hyperlipidemia, diabetes, and nonalcoholic fatty liver disease. Nineteen MSG male mice were divided into HBOT treated and control groups at 12 weeks of ages. The HBOT group was treated...

Full description

Saved in:
Bibliographic Details
Main Authors: Koichi Tsuneyama, Yen-Chen Chen, Makoto Fujimoto, Yoshiyuki Sasaki, Wataru Suzuki, Tsutomu Shimada, Seiichi Iizuka, Mitsunobu Nagata, Masaki Aburada, Shao-Yuan Chen
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2011/380236
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551640484282368
author Koichi Tsuneyama
Yen-Chen Chen
Makoto Fujimoto
Yoshiyuki Sasaki
Wataru Suzuki
Tsutomu Shimada
Seiichi Iizuka
Mitsunobu Nagata
Masaki Aburada
Shao-Yuan Chen
author_facet Koichi Tsuneyama
Yen-Chen Chen
Makoto Fujimoto
Yoshiyuki Sasaki
Wataru Suzuki
Tsutomu Shimada
Seiichi Iizuka
Mitsunobu Nagata
Masaki Aburada
Shao-Yuan Chen
author_sort Koichi Tsuneyama
collection DOAJ
description The effect of hyperbaric oxygen treatment (HBOT) was examined using MSG mice, which are an animal model of obesity, hyperlipidemia, diabetes, and nonalcoholic fatty liver disease. Nineteen MSG male mice were divided into HBOT treated and control groups at 12 weeks of ages. The HBOT group was treated with hyperbaric oxygen from 12 to 14 weeks (first phase) and then from 16 to 18 weeks (second phase). Interestingly, the body weight of the HBOT group was significantly lower (P<0.01) than that of the control group. In contrast, the serum lipid level did not show significant changes between the two groups. As for the effects of increasing oxidative stress, the liver histology of the HBOT group showed severer cellular damage and aberrant TNF-α expression. HBOT has the advantage of improving obesity in patients with metabolic syndrome, but the fault of causing organ damage by increasing oxidative stress.
format Article
id doaj-art-e1ff57c336f54aa6a9ec47a29b9f2e48
institution Kabale University
issn 1537-744X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-e1ff57c336f54aa6a9ec47a29b9f2e482025-02-03T06:00:59ZengWileyThe Scientific World Journal1537-744X2011-01-01112124213510.1100/2011/380236380236Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and SteatohepatitisKoichi Tsuneyama0Yen-Chen Chen1Makoto Fujimoto2Yoshiyuki Sasaki3Wataru Suzuki4Tsutomu Shimada5Seiichi Iizuka6Mitsunobu Nagata7Masaki Aburada8Shao-Yuan Chen9Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, JapanDepartment of Microbiology and Immunology, National Defense Medical Center, Taipei, TaiwanDepartment of Japanese Oriental Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, JapanInstitute for Animal Reproduction, 1103 Fukaya, Kasumigaura-shi, Ibaraki 300-0134, JapanFaculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, JapanFaculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, JapanFaculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, JapanFaculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, JapanFaculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, JapanSchool of Medicine, Fu Jen Catholic University, New Taipei City, TaiwanThe effect of hyperbaric oxygen treatment (HBOT) was examined using MSG mice, which are an animal model of obesity, hyperlipidemia, diabetes, and nonalcoholic fatty liver disease. Nineteen MSG male mice were divided into HBOT treated and control groups at 12 weeks of ages. The HBOT group was treated with hyperbaric oxygen from 12 to 14 weeks (first phase) and then from 16 to 18 weeks (second phase). Interestingly, the body weight of the HBOT group was significantly lower (P<0.01) than that of the control group. In contrast, the serum lipid level did not show significant changes between the two groups. As for the effects of increasing oxidative stress, the liver histology of the HBOT group showed severer cellular damage and aberrant TNF-α expression. HBOT has the advantage of improving obesity in patients with metabolic syndrome, but the fault of causing organ damage by increasing oxidative stress.http://dx.doi.org/10.1100/2011/380236
spellingShingle Koichi Tsuneyama
Yen-Chen Chen
Makoto Fujimoto
Yoshiyuki Sasaki
Wataru Suzuki
Tsutomu Shimada
Seiichi Iizuka
Mitsunobu Nagata
Masaki Aburada
Shao-Yuan Chen
Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
The Scientific World Journal
title Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
title_full Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
title_fullStr Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
title_full_unstemmed Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
title_short Advantages and Disadvantages of Hyperbaric Oxygen Treatment in Mice with Obesity Hyperlipidemia and Steatohepatitis
title_sort advantages and disadvantages of hyperbaric oxygen treatment in mice with obesity hyperlipidemia and steatohepatitis
url http://dx.doi.org/10.1100/2011/380236
work_keys_str_mv AT koichitsuneyama advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT yenchenchen advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT makotofujimoto advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT yoshiyukisasaki advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT watarusuzuki advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT tsutomushimada advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT seiichiiizuka advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT mitsunobunagata advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT masakiaburada advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis
AT shaoyuanchen advantagesanddisadvantagesofhyperbaricoxygentreatmentinmicewithobesityhyperlipidemiaandsteatohepatitis